https://www.indianpharmapost.com/mhra-clears-inavolisib-offering-new-option-for-returning-breast-cancer-184002025-11-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/europe-failing-to-diagnose-hiv-early-threatening-2030-aids-target-184012025-11-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/gan-lee-pharma-launches-phase-3-trial-of-once-monthly-weight-loss-jab-184022025-11-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/innocare-pharma-launches-global-phase-ii-trial-of-tyk2-inhibitor-for-prurigo-nodularis-in-china-184032025-11-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/a2z-wins-fda-nod-for-groundbreaking-abdomen-pelvis-ct-ai-triage-system-184042025-11-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/ascendis-pharmas-fda-review-of-achondroplasia-drug-gets-3-month-delay-184052025-11-30T00:00:00+05:30always0.9